Yoichiro Mitsuishi

3.3k total citations · 1 hit paper
40 papers, 2.4k citations indexed

About

Yoichiro Mitsuishi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yoichiro Mitsuishi has authored 40 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in Yoichiro Mitsuishi's work include Lung Cancer Treatments and Mutations (8 papers), Genomics, phytochemicals, and oxidative stress (4 papers) and RNA modifications and cancer (4 papers). Yoichiro Mitsuishi is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Genomics, phytochemicals, and oxidative stress (4 papers) and RNA modifications and cancer (4 papers). Yoichiro Mitsuishi collaborates with scholars based in Japan, United States and Chile. Yoichiro Mitsuishi's co-authors include Masayuki Yamamoto, Hozumi Motohashi, Yukie Kawatani, Keiko Taguchi, Tatsuhiro Shibata, Toshihiro Nukiwa, Hiroyuki Aburatani, Shunsuke Kitajima, Cloud P. Paweletz and Hideo Watanabe and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yoichiro Mitsuishi

39 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming

2012 1.1k citations Yoichiro Mitsuishi, Masayuki Yamamoto et al. profile →

Peers

Countries citing papers authored by Yoichiro Mitsuishi

Since Specialization

Citations

This map shows the geographic impact of Yoichiro Mitsuishi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoichiro Mitsuishi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoichiro Mitsuishi more than expected).

Fields of papers citing papers by Yoichiro Mitsuishi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoichiro Mitsuishi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoichiro Mitsuishi. The network helps show where Yoichiro Mitsuishi may publish in the future.

Co-authorship network of co-authors of Yoichiro Mitsuishi

This figure shows the co-authorship network connecting the top 25 collaborators of Yoichiro Mitsuishi. A scholar is included among the top collaborators of Yoichiro Mitsuishi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoichiro Mitsuishi. Yoichiro Mitsuishi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Second malignancy in advanced or recurrent non‐small cell lung cancer after the advent of molecular targeted drugs and immunotherapy 2024 ·Thoracic Cancer ·(unknown), Takehito Shukuya, (unknown), (unknown), Kana Kurokawa, Ikuko Nakamura, Taichi Miyawaki, (unknown), Tetsuhiko Asao, (unknown), (unknown), (unknown), Yoichiro Mitsuishi, Ken Tajima, (unknown), (unknown)	1
2	Multimodal fully automated predictive model for therapeutic efficacy of first-line cancer immunotherapy based on clinical information and imaging modalities including brain MRI and chest CT images in advanced non-small cell lung cancer. 2024 ·Journal of Clinical Oncology ·Taichi Miyawaki, (unknown), Kazuhiro Suzuki, (unknown), Yusuke Nakamura, (unknown), (unknown), (unknown), Masahiro Fujioka, (unknown), (unknown), Tetsuhiko Asao, (unknown), (unknown), Yoichiro Mitsuishi, (unknown), Ken Tajima, Naoko Shimada, Yujiro Otsuka, Kazuhisa Takahashi	1
3	Anti‐Müllerian hormone type II receptor protein expression in non‐small cell lung cancer and the effect of AMH/AMHR2 signaling on cancer cell proliferation 2024 ·Thoracic Cancer ·(unknown), Yoichiro Mitsuishi, Wira Winardi, Moulid Hidayat, (unknown), Daisuke Hayakawa, (unknown), N Matsumoto, Takuo Hayashi, (unknown), Ken Tajima, Kazuya Takamochi, Fumiyuki Takahashi, Kenji Suzuki, Kazuhisa Takahashi	1
4	Lymphangioleiomyomatosis as a potent lung cancer risk factor: Insights from a Japanese large cohort study 2024 ·Respirology ·(unknown), Takehito Shukuya, Kohei Uemura, Takuo Hayashi, Toshihide Ueno, Shinji Kohsaka, Yoshihiro Masui, (unknown), (unknown), Tetsuhiko Asao, Yoichiro Mitsuishi, Naoko Shimada, Fumiyuki Takahashi, Kazuya Takamochi, (unknown), Kazuhisa Takahashi, Kuniaki Seyama	2
5	A case of middle-aged central sleep apnea due to Joubert syndrome with different treatment effects of oxygen and acetazolamide 2024 ·Journal of Clinical Sleep Medicine ·(unknown), Satomi Shiota, (unknown), K Katsu, (unknown), Yoshihiko Sato, Yoichiro Mitsuishi, (unknown), Fusae Kawana, Takatoshi Kasai, Toshiaki Akashi, Kazuhisa Takahashi	1
6	Early Detection of Therapeutic Benefit from PD-1/PD-L1 Blockade in Advanced Lung Cancer by Monitoring Cachexia-Related Circulating Cytokines 2023 ·Cancers ·(unknown), Keita Miura, Takehito Shukuya, Sonoko Harada, Masahiro Fujioka, Wira Winardi, (unknown), Kana Kurokawa, (unknown), Taichi Miyawaki, Tetsuhiko Asao, Yoichiro Mitsuishi, Ken Tajima, Fumiyuki Takahashi, Takuo Hayashi, Norihiro Harada, Kazuhisa Takahashi	1
7	Clinical and genetic features of 334 Asian patients with Birt–Hogg–Dubé syndrome (BHDS) who presented with pulmonary cysts with or without a history of pneumothorax, with special reference to BHDS-associated pneumothorax 2023 ·PLoS ONE ·Yukiko Namba, Hiroki Ebana, (unknown), Etsuko Kobayashi, Masatoshi Kurihara, (unknown), (unknown), (unknown), Yoichiro Mitsuishi, Kazuhisa Takahashi, Kuniaki Seyama	5
8	CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma 2023 ·Thoracic Cancer ·(unknown), Kentaro Suina, Takehito Shukuya, Fumiyuki Takahashi, Takuo Hayashi, Kieko Hara, Tsuyoshi Saito, Yoichiro Mitsuishi, (unknown), Wira Winardi, Ken Tajima, Ryo Ko, (unknown), Tetsuhiko Asao, Masayoshi Itoh, Hideya Kawaji, Yoshiyuki Suehara, Kazuya Takamochi, Kenji Suzuki, Kazuhisa Takahashi	6
9	Survival past five years with advanced, EGFR-mutated or ALK-rearranged non-small cell lung cancer—is there a “tail plateau” in the survival curve of these patients? 2022 ·BMC Cancer ·(unknown), Takehito Shukuya, Tetsuhiko Asao, Daisuke Hayakawa, Kana Kurokawa, (unknown), Keita Miura, Yoichiro Mitsuishi, Ken Tajima, (unknown), Naoko Shimada, Fumiyuki Takahashi, Kazuhisa Takahashi	20
10	SCLC-J1, a novel small cell lung cancer cell line 2021 ·Biochemistry and Biophysics Reports ·(unknown), (unknown), Jun Ando, (unknown), Midori Ishii, (unknown), Yoichiro Mitsuishi, Tetsuhiko Asao, Ken Tajima, Taketsugu Yamamoto, Fumiyuki Takahashi, Norio Komatsu, Kazuhisa Takahashi, Miki Ando	4
11	Genetic Ancestry Contributes to Somatic Mutations in Lung Cancers from Admixed Latin American Populations 2020 ·Cancer Discovery ·Jian Carrot‐Zhang, Giovanny Soca‐Chafre, Nick Patterson, Aaron R. Thorner, Anwesha Nag, Jacqueline Watson, Giulio Genovese, July Rodríguez, (unknown), Luis Corrales, Yoichiro Mitsuishi, Gavin Ha, Joshua D. Campbell, Geoffrey R. Oxnard, Óscar Arrieta, Andrés F. Cardona, Alexander Gusev, Matthew Meyerson	71
12	Hermansky-Pudlak syndrome-associated pneumothorax with rapid progression of respiratory failure: a case report 2020 ·BMC Pulmonary Medicine ·Yukari Kato, Motoyasu Kato, Hiroaki Ihara, (unknown), (unknown), Keita Miura, Tomoko Yamada, Yoichiro Mitsuishi, Takehito Shukuya, Jun Ito, Takeshi Matsunaga, Tadashi Sato, Kenji Suzuki, Kazuhisa Takahashi	1
13	MGA suppresses the MYC pathway in lung adenocarcinoma 2019 ·Yoichiro Mitsuishi	1
14	23-valent pneumococcal polysaccharide vaccine improves survival in dialysis patients by preventing cardiac events 2019 ·Vaccine ·Hiroaki Ihara, Kan Kikuchi, (unknown), Shogo Fujita, Yuki Tsuruta, Motoyasu Kato, Yoichiro Mitsuishi, Ken Tajima, Yuzo Kodama, Fumiyuki Takahashi, Kazuhisa Takahashi, Nakanobu Azuma	12
15	Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer 2018 ·Cancer Discovery ·Shunsuke Kitajima, Elena V. Ivanova, Sujuan Guo, Ryohei Yoshida, Marco Campisi, Shriram K. Sundararaman, Shoichiro Tange, Yoichiro Mitsuishi, Tran C. Thai, Sayuri Masuda, Brandon Piel, Lynette M. Sholl, Paul T. Kirschmeier, Cloud P. Paweletz, Hideo Watanabe, Mamiko Yajima, David A. Barbie	348
16	Dasatinib Suppresses TGFβ-Mediated Epithelial–Mesenchymal Transition in Alveolar Epithelial Cells and Inhibits Pulmonary Fibrosis 2018 ·Lung ·(unknown), Fumiyuki Takahashi, Motoyasu Kato, Yoichiro Mitsuishi, Ken Tajima, Hiroaki Ihara, Moulid Hidayat, (unknown), (unknown), Daisuke Hayakawa, Shigehiro Yagishita, Ryo Ko, Tadashi Sato, Norihiro Harada, Yuzo Kodama, Fariz Nurwidya, Shin‐ichi Sasaki, Shin‐ichiro Niwa, Kazuhisa Takahashi	20
17	Somatic Superenhancer Duplications and Hotspot Mutations Lead to Oncogenic Activation of the KLF5 Transcription Factor 2017 ·Cancer Discovery ·Xiaoyang Zhang, Peter S. Choi, Joshua M. Francis, Galen F. Gao, Joshua D. Campbell, Aruna Ramachandran, Yoichiro Mitsuishi, Gavin Ha, Juliann Shih, Francisca Vázquez, Aviad Tsherniak, Alison M. Taylor, Jin Zhou, Zhong Wu, Ashton C. Berger, Marios Giannakis, William C. Hahn, Andrew D. Cherniack, Matthew Meyerson	85
18	The Nuclear Factor Erythroid 2–Related Factor 2 Activator Oltipraz Attenuates Chronic Hypoxia–Induced Cardiopulmonary Alterations in Mice 2013 ·American Journal of Respiratory Cell and Molecular Biology ·(unknown), Yasushi Hoshikawa, Takashi Moriguchi, Yoichiro Mitsuishi, Hironori Satoh, Kazuyuki Ishida, Tatsuaki Watanabe, Tôru Shimizu, Hiroaki Shimokawa, Yoshinori Okada, Masayuki Yamamoto, Takashi Kondo	48
19	Changes in Clinical Characteristics of Sarcoidosis Before and After New Diagnostic Criteria and Change Ratio of sIL-2R as A Prognostic Marker 2013 ·Koji Murakami, Tsutomu Tamada, Masayuki Nara, Yoichiro Mitsuishi, (unknown), (unknown), Masakazu Ichinose	0
20	The Keap1–Nrf2 system in cancers: stress response and anabolic metabolism 2012 ·SHILAP Revista de lepidopterología ·Yoichiro Mitsuishi, Hozumi Motohashi, Masayuki Yamamoto	317

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact